Remote Pharmacy Releases 2025 Availability Update on GLP-1 Weight Loss Solutions and Consumer Interest in Semaglutide & Tirzepatide
Bowling Green, July 03, 2025 (GLOBE NEWSWIRE) --
Section 1 – Introduction
In 2025, the discourse surrounding prescription weight loss treatments is gaining momentum, fueled by increasing public awareness of GLP-1 receptor agonists, such as semaglutide and tirzepatide. Developed initially as antidiabetic agents, these medications are now at the forefront of interest in physician-monitored, non-surgical weight management protocols. The surge in online traffic related to terms like 'GLP-1 weight loss treatment,' 'semaglutide injections for weight loss,' and 'tirzepatide therapy' is a clear sign of a cultural shift towards science-based, regulated solutions over unverified or fad-driven alternatives.
This evolution is taking place alongside a broader redefinition of healthcare delivery itself. As more consumers seek accessible, discreet, and flexible care models, telehealth platforms like Remote Pharmacy have become essential vehicles for accessing physician-guided prescription options from the comfort of their own homes, particularly in areas such as metabolic health, where continuity and personalization are crucial. Remote Pharmacy, as a telehealth platform, facilitates the connection between patients and U.S.-licensed physicians, ensuring safe and convenient access to prescription-based weight management options.
Today's health-conscious consumer is no longer swayed solely by brand name recognition or conventional in-office protocols. Instead, there is a growing interest in non-branded GLP-1 compounds, compounded semaglutide with vitamin B12, and other clinically reviewed alternatives available through compliant pharmacy networks. This shift in consumer behavior reflects a broader desire for affordability, customization, and most importantly, licensed oversight, rather than just rapid results or commercial hype.
As the weight management segment continues to evolve, individuals are increasingly seeking information-driven, regulated access to therapies that align with their long-term lifestyle goals. Remote Pharmacy's platform, which delivers professional review, pharmacist fulfillment, and secure, HIPAA-compliant infrastructure, is instrumental in shaping the future of prescription-based weight management. It meets modern expectations of care, offering a unique blend of convenience, safety, and personalization.
Section 2 – Product/Company Update
Remote Pharmacy announces continued nationwide availability of its compounded GLP-1 formulations, including semaglutide and tirzepatide-based treatments, for eligible adults pursuing physician-directed weight management. The platform provides 100% virtual consultations, with prescriptions evaluated and dispensed by U.S.-licensed healthcare professionals through independent third-party medical groups and pharmacies.
For informational access to physician-reviewed compounded GLP-1 treatment pathways, visit www.remotepharmacy.com.
Patients may begin the intake process through a secure digital health questionnaire, reviewed by an independent medical provider. Instead, it offers a digital platform that enables individuals to access healthcare consultations and prescription fulfillment via licensed providers. All medical decisions and prescriptions are managed exclusively by third-party providers.
Treatments are tailored to individual medical history, intake forms, and professional review. Doses are determined case-by-case — without tiered pricing or promotional variance — and may include compounded semaglutide with vitamin B12. Solutions are sourced from 503A-certified U.S. pharmacies and shipped discreetly to approved patients within 3–5 business days.
Remote Pharmacy's offerings include multiple GLP-1 options, such as:
Compounded Semaglutide injections
Tirzepatide in dissolvable or oral formats
Non-branded GLP-1 alternatives
Each option is reviewed through a secure medical intake form and physician consultation, with no video calls required. All services are conducted in compliance with HIPAA privacy protocols and applicable telehealth regulations.
Section 3 – Consumer Trend Overview
Increased search interest in 'prescription weight loss,' 'GLP-1 medication for weight loss,' and 'semaglutide vs tirzepatide' reflects a changing consumer mindset. Rather than pursuing rapid or unregulated solutions, more individuals are seeking medical oversight, scientific transparency, and safe pathways to long-term metabolic support.
Recent data suggests that U.S. adults are becoming more familiar with terms like 'GLP-1 agonist,' 'non-branded weight loss medication,' and 'compounded semaglutide,' signaling both awareness and demand. Online conversations have also shifted in tone — away from one-size-fits-all products and toward medically supervised approaches that offer privacy, customization, and consistency.
This growing awareness coincides with a broader preference for digital-first health models. Consumers increasingly value asynchronous consultations, flexible intake processes, and delivery options that do not require pharmacy pickups or clinic visits. As part of that evolution, patients are actively comparing GLP-1-based options based on ingredient profile, route of administration, and physician access — not brand loyalty or promotional claims.
Platforms offering a range of prescription-based GLP-1 treatments, such as semaglutide injections or oral tirzepatide, are gaining visibility among adults seeking solutions that feel medically grounded yet logistically simple. Search behavior shows a rise in queries for 'telehealth weight loss prescriptions,' 'GLP-1 compounded injections,' and 'custom weight loss plan with doctor review,' indicating demand for precision over generalization.
Remote Pharmacy's infrastructure — built to support U.S.-licensed prescribers, pharmacy fulfillment, and HIPAA-compliant access — reflects the priorities of this consumer base. For informational access to compounded GLP-1 treatment pathways, visit www.remotepharmacy.com. Learn more about how Remote Pharmacy facilitates HIPAA-compliant access to GLP-1 compounds prescribed by licensed providers. Individuals interested in physician-directed weight management options can review eligibility via the Remote Pharmacy patient portal. The platform offers informational access without marketing pressure and provides a structure that places clinical review at the center of the weight loss conversation.
Section 4 – Ingredient/Technology Spotlight
Semaglutide and tirzepatide remain the most searched GLP-1-related compounds in 2025, as both have gained prominence in the context of non-branded, physician-prescribed weight management protocols. Each compound offers a distinct pharmacological profile and delivery pathway, with compounded options tailored by licensed prescribers based on an individual's medical history and treatment eligibility.
Semaglutide is frequently cited in clinical literature for its role in regulating blood glucose levels and modulating satiety signals. In a compounded format, it may be paired with vitamin B12 for supportive wellness alignment. Vitamin B12, while not a therapeutic agent for weight management, is often included in wellness-focused regimens due to its role in energy metabolism and its support for overall nutrient balance, which can be beneficial in a weight management program.
Tirzepatide is a dual GLP-1 and GIP receptor agonist, discussed in recent studies for its role in regulating multiple metabolic pathways. Compounded tirzepatide is available in non-injection formats, such as oral drops and dissolvable tablets, broadening access for individuals seeking alternatives to injectable protocols. This non-branded availability is subject to regulatory compounding oversight and individual prescription review.
Remote Pharmacy's affiliated providers may prescribe compounded versions of these agents after reviewing the patient's submitted intake and determining suitability. All ingredients are compounded in 503A-certified pharmacies and dispensed in accordance with U.S. pharmacy laws.
No weight loss outcomes are implied or guaranteed. The use of semaglutide, tirzepatide, or B12 is guided solely by licensed medical discretion and the individual's clinical profile. These formulations are not substitutes for clinical treatment of obesity or metabolic disease and are intended for eligible adults within a physician-directed care model.
Section 5 – User Journey and Market Tone
Public discussions around GLP-1 weight management increasingly focus on the patient journey — from eligibility screening to virtual prescribing and pharmacy coordination. Consumers are gravitating toward models that offer simplicity, discretion, and clinical legitimacy, particularly when exploring treatments like compounded semaglutide or tirzepatide under the guidance of a medical professional.
Across forums and healthcare threads, prospective patients frequently express interest in secure, asynchronous platforms that enable them to initiate care at their convenience. As video visits are not required, many find value in the ability to complete a private intake form and receive prescription approval after physician review, especially when compared to in-office consultations that may feel rushed or limited in scope.
Remote Pharmacy's technology-enabled model reflects this evolving preference. Individuals who qualify are supported by licensed third-party providers who manage all medical determinations, including treatment selection and dosing. A secure patient portal offers real-time access to prescription updates, order history, and support options. This structure reinforces patient confidence without exerting promotional influence, thereby placing the decision-making authority in the hands of licensed professionals.
Many adults exploring GLP-1 prescription options report prioritizing ease of access, pharmacy reliability, and compliance with U.S. telehealth regulations. There is growing rejection of platforms that rely on promotional tactics, and increased demand for those that deliver transparent terms, fixed pricing, and optionality in format, such as oral tirzepatide or weekly compounded semaglutide injections.
Rather than framing the journey as product-first, patient narratives increasingly reflect a process-focused mindset: one that values accuracy, physician engagement, and the ability to control treatment pace without pressure. In this context, Remote Pharmacy's offering is experienced not as a sales mechanism, but as a compliant access point for individualized care through a licensed provider network.
Section 6 – Availability and Transparency
Remote Pharmacy's weight loss solutions are available to eligible adults located within states where prescribing services are legally offered through the platform's independent clinical partners. All prescriptions require prior approval from a licensed physician and are evaluated based on submitted medical intake data. Access to compounded GLP-1 treatments, including semaglutide and tirzepatide, is subject to individual suitability and the discretion of third-party providers.
Remote Pharmacy does not offer medical advice or diagnostic services. Instead, it facilitates secure, HIPAA-compliant access to licensed prescribers and 503A-certified U.S. pharmacies that independently manage patient evaluations and prescription fulfillment. Remote Pharmacy does not make medical decisions and is not influenced by its administrative role on the platform.
Product availability, including format (injectable, dissolvable, or oral), is determined solely by the prescribing provider and may vary by location, compound stability, or the compounding pharmacy's capacity. Delivery times are typically 3–5 business days after approval and fulfillment, but may vary depending on pharmacy operations and shipping logistics.
The information provided on Remote Pharmacy's website and intake portals is intended for general awareness only. No therapeutic outcomes are implied or guaranteed. Individuals should consult a qualified healthcare professional to determine the appropriateness of any treatment. Prescription access through Remote Pharmacy aligns with current U.S. telehealth regulations and is designed to facilitate informational engagement with independently licensed providers.
Section 7 – Industry Context and Final Observations
The growth of digital healthcare models has transformed how consumers engage with prescription therapies, particularly in areas such as weight management and metabolic wellness. As interest in GLP-1 receptor agonists expands, patients are increasingly drawn to prescription platforms that prioritize accessibility, provider discretion, and compound integrity, rather than promotional campaigns or tiered pricing.
The rise of compounded GLP-1 formulations, including semaglutide and tirzepatide, signals a notable shift in the healthcare landscape. Once limited to specialty settings, compounded medications are now entering mainstream demand as regulated, physician-directed alternatives. For many individuals, these formulations offer options that align with personal health goals and logistical needs, especially when dispensed through 503A-certified U.S. pharmacies with provider oversight.
Telehealth is no longer viewed as a temporary solution, but rather as a standard pathway for clinical engagement. From asynchronous consultations to digital refill management, the patient experience has moved beyond location-bound models. Today's platforms must offer more than convenience — they must demonstrate compliance, transparency, and adaptability to individual needs.
Remote Pharmacy's technology-enabled framework reflects these new expectations. By separating its administrative platform from the clinical and pharmaceutical responsibilities of third-party partners, it maintains a neutral stance while enabling lawful prescription access. This model fosters consumer trust while avoiding the common pitfalls of unregulated online marketplaces and exaggerated marketing claims.
As the industry continues to evolve, regulated platforms offering secure access to licensed prescribers and independently dispensed, non-branded medications are likely to define the future of weight-related telehealth.
For a closer look at how digital pharmacy infrastructure is evolving, visit www.remotepharmacy.com
Section 8 – Public Commentary Theme Summary
Public discussions around GLP-1 medications and physician-directed weight loss care have grown more nuanced in 2025. A review of online discourse, forum threads, and social media commentary reveals consistent themes, with interest and caution often expressed in parallel.
A recurring point of interest involves the distinction between branded medications and compounded alternatives. Some individuals have noted curiosity about whether non-branded formulations offer greater flexibility, mainly when prescribed by licensed providers and dispensed through accredited compounding pharmacies. Others have expressed appreciation for asynchronous intake methods that reduce the barriers to access, while still preserving professional oversight.
Concerns about over-marketed platforms and variable pricing models are also frequently raised. Public commentary often reflects a desire for fixed-cost structures, transparent eligibility requirements, and clearer communication from providers. In this context, services that avoid tiered plans, aggressive promotions, or comparisons to brand-name drugs resonate with individuals seeking a clinical, unbiased experience.
There is also growing interest in format diversity. Some consumers prefer injectables prescribed by a physician, while others opt for oral or dissolvable delivery forms, particularly for their potential alignment with daily routines. While discussions often cite motivation or lifestyle fit, users typically acknowledge that outcomes vary and that consistency, rather than speed, is the primary focus.
Importantly, commentary acknowledges that access to compounded GLP-1 does not guarantee weight loss or clinical transformation. Individuals appear increasingly aware of the role physician discretion plays in determining suitability, and are open about the need for ongoing communication with providers.
This public tone suggests that consumers are approaching compounded GLP-1 treatments not as quick solutions, but as part of an informed, regulated health decision that balances access with accountability.
About Remote Pharmacy
Remote Pharmacy is a U.S.-based technology platform that enables individuals to access physician-reviewed, pharmacy-dispensed treatments through affiliated third-party providers. The company does not practice medicine or dispense pharmaceuticals; instead, it facilitates access to virtual healthcare in compliance with applicable laws. Its platform prioritizes discretion, HIPAA compliance, and user privacy, with no marketing-driven pricing or usage claims. Remote Pharmacy does not provide diagnostic or disease-treatment services; its offerings are for informational use only, in the context of wellness and lifestyle support.
Contact:
Remote Pharmacy
Email: support@remotepharmacy.com
Website: www.remotepharmacy.com
CONTACT: Email: support@remotepharmacy.com Website: www.remotepharmacy.comSign in to access your portfolio
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
22 minutes ago
- Yahoo
I'm a Dietitian. This Is the One Food I'm Trying to Eat More Often
As a dietitian, I'm not one to overhype any particular food for its nutritional benefits, but there is one humble pantry staple I'm personally trying to eat more often: beans. Whether they're canned, dried, or sneakily blended into soups, salads, or dips, beans are packed with powerful nutrients and offer some of the biggest health payoffs for the lowest cost and effort. Yet despite all they offer, they're seriously under-consumed in most American diets. Let's discuss the science behind why I'm working to include them more often, and why you should Dietary Guidelines recommend that adults consume about 1.5 cups of legumes per week, which can be divided into a half-cup serving three times a week. That's not much, but most of us still fall short. Eating beans also helps increase fiber, plant-based protein, and nutrients like potassium and B vitamins. Additionally, nearly 9 out of 10 Americans fail to meet the recommended fiber intake, which is 25 grams per day for women and 38 grams for men. Beans happen to be one of the richest sources of both soluble and insoluble fiber. And eating enough fiber supports better digestive health, regulates your blood sugar, and keeps you feeling full. You can think of fiber like the 'broom' that comes in to sweep out your gut, clearing out toxins, binding waste, and helping excrete excess hormones and cholesterol. Plus, eating enough fiber helps digestion run smoothly and keeps you a dietitian, I already knew beans were good for you. But lately, I've been more intentional about eating them regularly, and here's why: One of the biggest reasons I've been reaching for more beans is their impressive fiber content in a serving, especially soluble fiber. Soluble fiber dissolves in water and forms a gel-like substance in the digestive tract, which helps lower LDL ('bad') cholesterol, slows the absorption of sugar, and feeds beneficial gut bacteria. This can have a powerful impact on heart health, blood sugar control, and digestive regularity. A half-cup of black beans delivers around 7 to 8 grams of fiber, putting a major dent in the recommended 25 to 38 grams per day. Research shows that diets high in fiber are linked to lower risks of cardiovascular disease, type 2 diabetes, and colorectal cancer, yet most of us are still falling far short. Eating beans regularly is a simple and effective way to close that gap. Beans are also a fantastic source of plant-based protein, with 7 to 9 grams per half-cup cooked serving, depending on the variety. This makes them especially valuable for vegetarians, vegans, or anyone looking to reduce their intake of animal protein. But it's not just about protein quantity, it's also about the total impact on health. Studies have shown that replacing animal proteins with plant proteins like those found in legumes is associated with a lower risk of heart disease, type 2 diabetes, and even some cancers. Plus, plant-based proteins tend to come bundled with beneficial nutrients like fiber and antioxidants, rather than the saturated fat or cholesterol found in some animal products. Beans can help you boost your protein intake while supporting your long-term health goals. Beans may not get the same spotlight as trendy superfoods, but they're nutrient-dense powerhouses. In addition to fiber and protein, they contain a wide range of essential nutrients many Americans don't get enough of—including folate, magnesium, potassium, iron, and B vitamins. They're also rich in polyphenols and antioxidants, which help combat oxidative stress and inflammation. These nutrients play a key role in everything from energy metabolism and red blood cell formation to nerve function and muscle health. Potassium, for example, helps balance sodium and support healthy blood pressure. Yet it's one of the most commonly under-consumed nutrients in the U.S. In fact, it's been labeled a 'nutrient of concern' for Americans. Beans offer a budget-friendly, accessible way to fill those nutrient gaps and support whole-body you're not used to eating beans, start small. And if you're new to beans and concerned about bloating, try lentils or split peas first, and gradually increase your intake while drinking plenty of water. All legumes count here — some of the most common legumes you'll find at the store include black beans, chickpeas, lentils, kidney beans, pinto beans, and edamame. Here are a few easy, non-intimidating ways to get more into your meals: Toss them into salads or grain bowls for a satisfying boost. Blend into dips like hummus or white bean spread. Stir into pasta sauces or taco meat to stretch your protein. Add them to soups or stews for extra protein and fiber. Try bean-based snacks, like roasted chickpeas or lentil chips. Use canned beans for convenience and choose low-sodium or give them a rinse if you are looking for a low-salt option. Beans may be small, but their impact on health can be mighty. From fiber and protein to key vitamins and minerals, they deliver health benefits in every bite, like supporting heart health, gut health, blood sugar balance, and more. As a dietitian, I'm always looking for simple, easy ways to improve my own nutrition and help others do the same—and beans fit the bill perfectly. No matter how you enjoy them, adding more beans to your routine is a smart, satisfying step toward better health. I'm a Dietitian. This Is the One Food I'm Trying to Eat More Often first appeared on Men's Journal on Jul 4, 2025
Yahoo
22 minutes ago
- Yahoo
Here's what's in Trump's "big, beautiful bill" passed by Congress
Washington — The House passed a massive spending and tax bill that includes signature policies of President Trump's second-term agenda Thursday, sending the so-called "big, beautiful bill" to the president's desk ahead of a July 4 deadline. Mr. Trump signed the bill into law on Friday afternoon. The House approved the bill in a 218 to 214 vote Thursday, after the Senate narrowly approved the bill Tuesday in a 51-50 vote that required Vice President JD Vance to break a tie. At the center the "big, beautiful bill" is an extension of Mr. Trump's 2017 Tax Cuts and Jobs Act, which was slated to sunset at the end of the year. The legislation would make most of the tax cuts permanent, while increasing spending for border security, defense and energy production. The bill is partially paid for by significant cuts to health care and nutrition programs, like Medicaid and the Supplemental Nutrition Assistance Program, or SNAP. The Congressional Budget Office estimates the bill would add $3.4 trillion to federal deficits over the next 10 years and leave millions without health insurance. Republicans and the White House dispute those forecasts. Senate Republicans used a process known as budget reconciliation to pass the bill, which limits the types of policies that can be included in a simple majority vote. A handful of provisions that initially appeared in the bill were ultimately removed, including one that would have ordered the sale of public lands and another that would have paused state regulations on artificial intelligence. The House passed its own initial version of the legislation last month, with some key differences to the final Senate-crafted version. The lower chamber approved the Senate's changes Thursday, sending the measure to the president's desk. Here's what is in the 887-page bill: Medicaid restrictions The legislation includes restrictions on Medicaid, which provides government-sponsored health care for low-income and disabled Americans. The bill imposes work requirements for some able-bodied adults and more frequent eligibility checks. The Congressional Budget Office estimates that the bill would result in 11.8 million Americans losing health coverage under Medicaid over the next decade. The Senate parliamentarian determined that a measure cutting federal funds to states that use Medicaid infrastructure to provide health care coverage to undocumented immigrants, along with banning Medicaid from covering gender transition services, wasn't in compliance with Senate reconciliation rules. The parliamentarian also weighed in on what's known as the provider tax, which states use to help fund their portion of Medicaid costs, in a blow to the Senate GOP's initial plan. Senate Republicans proposed steeper cuts to Medicaid funding, in part by incrementally lowering provider taxes from 6% to 3.5% by 2032. The timeline is delayed by one year from the Senate GOP's initial proposal, after the issue became one of the bill's sticking points in recent weeks. It's a departure from the initial House-passed bill, which sought to lower federal costs by freezing states' provider taxes at current rates and prohibiting them from establishing new provider taxes. The bill also includes a rural hospital stabilization fund after some GOP senators expressed concern over how rural hospitals could be impacted by the Medicaid restrictions, allocating $50 billion for rural hospitals over the same period that the provider taxes would be lowered. Homeland security and immigration The legislation includes more than $46.5 billion for border wall construction and related expenses, $45 billion to expand detention capacity for immigrants in custody and about $30 billion in funding for hiring, training and other resources for U.S. Immigration and Customs Enforcement. It also includes a minimum $100 fee for those seeking asylum, down from the $1,000 fee outlined in the initial House bill. The Senate parliamentarian ruled out the $1,000 fee for anyone applying for asylum. Increasing the state and local tax deduction, or SALT The package also includes an increase to the cap on the state and local tax deduction, raising it from $10,000 to $40,000. After five years, it would return to $10,000, a departure from the initial House-passed bill. The issue was a major sticking point in the House, where blue-state Republicans threatened to withhold their support without the increase to the deduction. But with no Republicans hailing from blue states in the Senate, the upper chamber has been contending with its own dynamics. Before the rule, taxpayers could deduct all their state and local taxes from their federal taxes, which some policymakers have said mainly benefits wealthy homeowners in states with high taxes, such as New York and California. But advocates for increasing the caps argue that the $10,000 cap is increasingly impacting middle-class homeowners who live in regions where property taxes are rising. Green energy policies The final bill passed by the Senate would largely terminate numerous tax incentives from the 2022 Inflation Reduction Act for clean energy, electric vehicles and energy efficiency programs that benefited consumers. It would end tax credits for new and used electric vehicles, installation of home EV charging equipment and insulation or energy efficient heating and cooling systems. The bill also ends the Greenhouse Gas Reduction Fund, which gives funding to nonprofit organizations providing financing for projects that reduce pollution and greenhouse gas emissions in communities. Existing contracts and grants under the program are not affected. Restrictions on food stamps The bill still shifts the costs of SNAP, or food stamps, to some states. The program is currently fully funded by the federal government. The federal government would continue to fully fund the benefits for states that have an error payment rate below 6%, beginning in 2028. States with error rates above 6% would be on the hook for 5% to 15% of the costs. States are also given some flexibility in calculating their share. The package also aligns with the initial House version on age requirements for able-bodied adults to qualify for SNAP benefits. Currently, in order to qualify, able-bodied adults between 18 and 54 must meet work requirements. Both the Senate and House bills would update the age requirement to 18 and 64, with some exemptions for parents. Alaska and Hawaii could receive waivers for the work requirements if it's determined that they're making a "good faith effort" to comply. Addressing the debt limit The legislation would raise the debt ceiling by $5 trillion, going beyond the $4 trillion outlined in the initial House-passed bill. Congress faces a deadline to address the debt limit later this summer. Treasury Secretary Scott Bessent has urged Congress to address the debt limit by mid-July, saying that the U.S. could be unable to pay its bills as early as August, when Congress is on recess. By addressing the debt ceiling as part of the larger package, Republicans in Congress aimed to bypass negotiating with Democrats on the issue. Unlike most other legislation in the Senate, the budget reconciliation process that governs the package requires a simple majority, rather than the 60-vote threshold to move forward with a bill. Child tax credit The current $2,000 child tax credit is set to return to the pre-2017 level of $1,000 in 2026. The tax credit would permanently increase to $2,200 under the bill, $300 less than the initial House-passed hike. Limits on overtime and tips deductions The bill would allow individuals to deduct a certain amount of tip wages and overtime from their taxes. The provisions would expire in 2028. The "no tax on tips" provision in the spending bill would create a new deduction for tipped workers, eliminating what they owe in federal income tax. Tipped workers would still have to pay state and local income tax and payroll taxes. The Senate version varies from the initial House-passed provisions on a few key points, including how much a worker could claim in deductions. The Senate proposal limits that deduction to $25,000, while the early House version was uncapped. Under the initial House measure, meanwhile, only people with annual income of $160,000 or less would have qualified for the tipping tax break, while the Senate version phases out benefits for individuals whose income exceeds $150,000 or couples whose income exceeds $300,000. Changes to standard deduction The bill seeks to permanently expand the basic standard deduction, which was nearly doubled in 2017. The increases will expire at the end of the year. What a new DOJ memo could mean for naturalized U.S. citizens July 4 holiday week expected to set record for travelers Group meets to handwrite the U.S. Constitution
Yahoo
22 minutes ago
- Yahoo
When will Coloradans feel the impact of Trump's 'Big, Beautiful Bill?'
President Donald Trump's tax and spending bill will mean big changes for Coloradans, from the taxes you pay to Medicaid and immigration.
